導(dǎo)師類別：碩導(dǎo)
郵箱：taotao@zxbiomed.org
個人簡介
陶濤，深圳大學(xué)第三附屬醫(yī)院，精準(zhǔn)醫(yī)學(xué)研究院，副研究員。深圳市高層次人才。長期從事腫瘤領(lǐng)域臨床及基礎(chǔ)方面研究，獲得臨床執(zhí)業(yè)醫(yī)師證書。近五年內(nèi)已發(fā)表學(xué)術(shù)論文15篇，其中第一作者和共同通訊作者文章10篇，包括JCR一區(qū)雜志Advanced Science、Oncogene、Molecular Cancer、Cancer Letters。曾獲2017年北京市優(yōu)秀博士畢業(yè)論文獎，并獲2019年博士后基金項目資助。
主要研究方向
腫瘤微環(huán)境信息監(jiān)測，腫瘤相關(guān)細(xì)胞學(xué)研究，細(xì)胞治療
代表性成果等
(1)Liang T, Tao T*, Wu K, et al. Cancer‐Associated Fibroblast‐Induced Remodeling of Tumor Microenvironment in Recurrent Bladder Cancer Advanced Science, 2023, 10(2303230).
(2)Tao T#; Yang X#; Zheng J; Feng D; Qin Q; Shi X; Wang Q; Zhao C; Peng Z; Liu H*; Jiang W G; He J*; PDZK1 inhibits the development and progression of renal cell carcinoma by suppression of SHP-1 phosphorylation, Oncogene, 2017, 3 6(44): 6119-6131.
(3)Hongwei Su#; Tao Tao#; Zhao Yang#; Xing Kang; Xu Zhang; Danyue Kang; Song Wu*; Chong Li*; Circular RNA cTFRC acts as the sponge of MicroRNA-107 to promote bladder carcinoma progression, Molecular Cancer, 2019, 18(27).
(4)Tao Tao; Yang Xiaomei; Qin Qiong; Shi Wen; Wang Qiqi; Yang Ying; He Junqi*; NHERF1 Enhances Cisplatin Sensitivity in Human Cervical Cancer Cells, International Journal of Molecular Sciences, 2017, 18(1): 0-5.
(5)Zhao, Chunjuan#; Tao, Tao#; Yang, Longyan#; Qin, Qiong*; Wang, Ying; Liu, Hua; Song, Ran; Yang, Xiaomei; Wang, Qiqi; Gu, Siyu; Xiong, Ying; Zhao, Dong; Wang, Songlin; Feng, Duiping; Jiang, Wen G.; Zhang, Jun*; He, Junqi*; Los s of PDZK1 expression activates PI3K/AKT signaling via PTEN phosphorylation in gastric cancer , Cancer Letters, 2019, 453: 107-121.
照片
